These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Chronic reflux esophagitis with endobrachyesophagus and multifocal adenocarcinoma]. Lange U; Peek A; Bähr R; Frenzel H Leber Magen Darm; 1992 May; 22(3):121-4. PubMed ID: 1625510 [TBL] [Abstract][Full Text] [Related]
23. Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis. Jankowski J; Hopwood D; Pringle R; Wormsley KG Am J Gastroenterol; 1993 Mar; 88(3):402-8. PubMed ID: 8438848 [TBL] [Abstract][Full Text] [Related]
24. Reflux injury of esophageal mucosa: experimental studies in animal models of esophagitis, Barrett's esophagus and esophageal adenocarcinoma. Li Y; Martin RC Dis Esophagus; 2007; 20(5):372-8. PubMed ID: 17760649 [TBL] [Abstract][Full Text] [Related]
25. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study. Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297 [TBL] [Abstract][Full Text] [Related]
26. mRNA expression of inducible nitric oxide synthase, endothelial nitric oxide synthase and vascular endothelial growth factor in esophageal mucosa biopsy specimens from patients with reflux esophagitis. Inamori M; Shimamura T; Nagase H; Abe Y; Umezawa T; Nakajima A; Saito T; Ueno N; Tanaka K; Sekihara H; Togawa J; Kaifu H; Tsuboi H; Kayama H; Tominaga S Hepatogastroenterology; 2006; 53(69):361-5. PubMed ID: 16795973 [TBL] [Abstract][Full Text] [Related]
27. Pathogenesis of reflux esophagitis and Barrett's esophagus. Orlando RC Med Clin North Am; 2005 Mar; 89(2):219-41, vii. PubMed ID: 15656926 [TBL] [Abstract][Full Text] [Related]
28. Toll-like receptor 4 activation in Barrett's esophagus results in a strong increase in COX-2 expression. Verbeek RE; Siersema PD; Ten Kate FJ; Fluiter K; Souza RF; Vleggaar FP; Bus P; van Baal JW J Gastroenterol; 2014 Jul; 49(7):1121-34. PubMed ID: 23955118 [TBL] [Abstract][Full Text] [Related]
29. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence. Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; Comber H; McGuigan J; Reynolds JV; Murray LJ Cancer Res; 2006 May; 66(9):4975-82. PubMed ID: 16651456 [TBL] [Abstract][Full Text] [Related]
30. Is Barrett's esophagus the precursor of most adenocarcinomas of the esophagus and cardia? A biochemical study. Mendes de Almeida JC; Chaves P; Pereira AD; Altorki NK Ann Surg; 1997 Dec; 226(6):725-33; discussion 733-5. PubMed ID: 9409571 [TBL] [Abstract][Full Text] [Related]
31. Frequent methylation of eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma. Zou H; Osborn NK; Harrington JJ; Klatt KK; Molina JR; Burgart LJ; Ahlquist DA Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):830-4. PubMed ID: 15824152 [TBL] [Abstract][Full Text] [Related]
32. P53 and Ki-67 overexpression in gastroesophageal reflux disease--Barrett's esophagus and adenocarcinoma sequence. Binato M; Gurski RR; Fagundes RB; Meurer L; Edelweiss MI Dis Esophagus; 2009; 22(7):588-95. PubMed ID: 19302208 [TBL] [Abstract][Full Text] [Related]
33. Reflux esophagitis and Barrett esophagus. Hamilton SR Monogr Pathol; 1990; (31):11-68. PubMed ID: 2406572 [TBL] [Abstract][Full Text] [Related]
34. Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma. Derks S; Nason KS; Liao X; Stachler MD; Liu KX; Liu JB; Sicinska E; Goldberg MS; Freeman GJ; Rodig SJ; Davison JM; Bass AJ Cancer Immunol Res; 2015 Oct; 3(10):1123-1129. PubMed ID: 26081225 [TBL] [Abstract][Full Text] [Related]
35. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas. Washington K; Chiappori A; Hamilton K; Shyr Y; Blanke C; Johnson D; Sawyers J; Beauchamp D Mod Pathol; 1998 Sep; 11(9):805-13. PubMed ID: 9758359 [TBL] [Abstract][Full Text] [Related]
36. Myo9B is associated with an increased risk of Barrett's esophagus and esophageal adenocarcinoma. Menke V; Van Zoest KP; Moons LM; Pot RG; Siersema PD; Kuipers EJ; Kusters JG Scand J Gastroenterol; 2012 Dec; 47(12):1422-8. PubMed ID: 22954106 [TBL] [Abstract][Full Text] [Related]
37. Adenocarcinomas of the distal esophagus and "gastric cardia" are predominantly esophageal carcinomas. Chandrasoma P; Wickramasinghe K; Ma Y; DeMeester T Am J Surg Pathol; 2007 Apr; 31(4):569-75. PubMed ID: 17414104 [TBL] [Abstract][Full Text] [Related]
38. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia. Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862 [TBL] [Abstract][Full Text] [Related]
39. Association of manganese superoxide dismutase expression with progression of carcinogenesis in Barrett esophagus. Hermann B; Li Y; Ray MB; Wo JM; Martin RC Arch Surg; 2005 Dec; 140(12):1204-9; discussion 1209. PubMed ID: 16365243 [TBL] [Abstract][Full Text] [Related]
40. Reflux esophagitis and Barrett's esophagus: the diagnostic role of esophageal mucosal biopsies. Arvelo G; Marcial MA Bol Asoc Med P R; 1989 Sep; 81(9):351-4. PubMed ID: 2684195 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]